Dectromethorphan : (Record no. 8579)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00987nam a22001457a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20230317112805.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 230317b ph ||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | OCT |
| 240 ## - UNIFORM TITLE | |
| Uniform title | Journal of psychosocial nursing and mental health services / |
| Medium | November 2022 |
| 245 ## - TITLE STATEMENT | |
| Title | Dectromethorphan : |
| Remainder of title | from cough suppressant to antidepressant |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Thorofarem Jersey : |
| Name of publisher, distributor, etc. | Slack Incorporated, |
| Date of publication, distribution, etc. | 2022 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | Vol. 60 (11) : pages 9-11 |
| 500 ## - GENERAL NOTE | |
| General note | Dextromethorphan (DXM) has been repurposed several times over the past 7 decades: first as a cough suppressant, then as a compounded formulation with quinidine for treatment of pseudobulbar affect, and most recently as a compounded formulation with bupropion for treatment of major depressive disorder. The current article describes the history and purported mechanisms of action of DXM for each use and the uniquely rapid action and safety profile of the oral dextromethorphanbupropion antidepressant formulation. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Continuing Resources |
| Suppress in OPAC | No |
No items available.